About
Prof. Philip Elsinga is a Professor in PET Radiochemistry at the Faculty of Medical Sciences, University of Groningen (UMCG). He leads research in radiopharmaceutical development, molecular imaging, and theranostic applications. His expertise spans PET tracer design, bacterial infection imaging, and tumor microenvironment studies. He is Editor-in-Chief of EJNMMI Radiopharmacy and Chemistry and an expert advisor to the International Atomic Energy Agency (IAEA). Recent grants include a €10.5M award for Terbium isotope production in cancer theranostics.
- Research Focus: Radiotracer synthesis, immunoPET, bacterial infection imaging, and oncology applications
- Key Collaborations: SHINE Europe, MercaChemSyncom, and academic partners in Europe
His work bridges chemistry and clinical translation, with over 350 publications. Current projects include developing novel tracers for immune checkpoint inhibitors and optimizing isotope production for cancer treatment.
- Grants & Awards: €10.5M (2025), 2018 Fellowship for infection imaging research
- Labs/Teams: BRIDGE (Basic and Translational Research and Imaging Methodology Development)
